PCSK9 and Hepatic fibrosis: While the abovementioned studies examined the potential contribution of PCSK9 to the severity and progression of inflammation, several reports suggest PCSK9 to contribute to the early steps of hepatic inflammation, which is the main driver of liver injury and leads to liver fibrosis and cirrhosis [97].